# S-1 Versus S-1 Plus Cisplatin as an Adjuvant Chemotherapy to Treat Gastric Cancer

> **NCT01426646** · PHASE2 · UNKNOWN · sponsor: **Kyungpook National University Hospital** · enrollment: 218 (estimated)

## Conditions studied

- Gastric Cancer

## Interventions

- **DRUG:** S-1
- **DRUG:** S-1 plus cisplatin

## Key facts

- **NCT ID:** NCT01426646
- **Lead sponsor:** Kyungpook National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-09
- **Primary completion:** 2014-09
- **Final completion:** 2016-09
- **Target enrollment:** 218 (ESTIMATED)
- **Last updated:** 2012-01-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01426646

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01426646, "S-1 Versus S-1 Plus Cisplatin as an Adjuvant Chemotherapy to Treat Gastric Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01426646. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*